• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

七种自身抗体联合列线图评分表预测非小细胞肺癌风险的诊断价值。

The diagnostic value of a seven-autoantibody panel and a nomogram with a scoring table for predicting the risk of non-small-cell lung cancer.

机构信息

Department of Thoracic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

出版信息

Cancer Sci. 2020 May;111(5):1699-1710. doi: 10.1111/cas.14371. Epub 2020 Mar 19.

DOI:10.1111/cas.14371
PMID:32108977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7226194/
Abstract

The early detection of non-small-cell lung cancer (NSCLC) remains a common concern. The aim of our study was to validate the diagnostic value of a seven-autoantibody (7-AAB) panel compared with radiological diagnosis for NSCLC. We constructed a nomogram and a scoring table based on the 7-AAB panel's result to predict the risk of NSCLC. We prospectively enrolled 268 patients who presented with radiological lesions and underwent both the 7-AAB panel test and pathological diagnosis by surgical resection. A comparison between the 7-AAB panel and radiological diagnosis was performed. A nomogram and a scoring table based on the 7-AAB panel's result to predict the risk of NSCLC were constructed and internally validated. The 7-AAB panel test had a specificity of 90.2% and a positive predictive value (PPV) of 92.7%, which were significantly higher than those of the radiological diagnosis. The 7-AAB panel also showed a preferable sensitivity in patients with early-stage disease. Seven factors, including the 7-AAB panel results, were integrated into the nomogram. For more convenient application, we formulated a scoring table based on the nomogram. The area under the receiver operating characteristic curve was 0.840 and 0.860 in the training group and validation group, respectively, which was higher than that using the 7-AAB panel or radiological diagnosis alone. This study reveals that our 7-AAB panel has clinical value in the diagnosis of NSCLC. The utility of our nomogram and the scoring table indicated that they have the potential to assist clinicians in avoiding unnecessary treatment or needless follow-up.

摘要

早期发现非小细胞肺癌(NSCLC)仍然是一个常见的关注点。我们的研究目的是验证七种自身抗体(7-AAB)panel 与影像学诊断 NSCLC 的诊断价值。我们构建了一个列线图和评分表,基于 7-AAB panel 的结果来预测 NSCLC 的风险。我们前瞻性地招募了 268 名有影像学病变且接受 7-AAB panel 检测和手术切除病理诊断的患者。比较了 7-AAB panel 和影像学诊断。构建了基于 7-AAB panel 结果预测 NSCLC 风险的列线图和评分表,并进行了内部验证。7-AAB panel 检测的特异性为 90.2%,阳性预测值(PPV)为 92.7%,明显高于影像学诊断。7-AAB panel 在早期疾病患者中也显示出更好的敏感性。将 7 个因素,包括 7-AAB panel 的结果,整合到列线图中。为了更方便的应用,我们根据列线图制定了一个评分表。训练组和验证组的受试者工作特征曲线下面积分别为 0.840 和 0.860,高于单独使用 7-AAB panel 或影像学诊断的结果。本研究表明,我们的 7-AAB panel 在 NSCLC 的诊断中有临床价值。我们的列线图和评分表的实用性表明,它们有可能帮助临床医生避免不必要的治疗或随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c009/7226194/618c215e7c94/CAS-111-1699-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c009/7226194/0264dfb66728/CAS-111-1699-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c009/7226194/3c704c7766fb/CAS-111-1699-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c009/7226194/bfbb02c0a115/CAS-111-1699-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c009/7226194/dd65c730c54c/CAS-111-1699-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c009/7226194/618c215e7c94/CAS-111-1699-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c009/7226194/0264dfb66728/CAS-111-1699-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c009/7226194/3c704c7766fb/CAS-111-1699-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c009/7226194/bfbb02c0a115/CAS-111-1699-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c009/7226194/dd65c730c54c/CAS-111-1699-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c009/7226194/618c215e7c94/CAS-111-1699-g005.jpg

相似文献

1
The diagnostic value of a seven-autoantibody panel and a nomogram with a scoring table for predicting the risk of non-small-cell lung cancer.七种自身抗体联合列线图评分表预测非小细胞肺癌风险的诊断价值。
Cancer Sci. 2020 May;111(5):1699-1710. doi: 10.1111/cas.14371. Epub 2020 Mar 19.
2
The combination of a seven-autoantibody panel with computed tomography scanning can enhance the diagnostic efficiency of non-small cell lung cancer.七自身抗体检测组合与计算机断层扫描相结合可提高非小细胞肺癌的诊断效率。
Front Oncol. 2022 Nov 30;12:1047019. doi: 10.3389/fonc.2022.1047019. eCollection 2022.
3
The Value of a Seven-Autoantibody Panel Combined with the Mayo Model in the Differential Diagnosis of Pulmonary Nodules.七项自身抗体联合 Mayo 模型在肺结节鉴别诊断中的价值。
Dis Markers. 2021 Feb 18;2021:6677823. doi: 10.1155/2021/6677823. eCollection 2021.
4
Improving the efficiency of identifying malignant pulmonary nodules before surgery via a combination of artificial intelligence CT image recognition and serum autoantibodies.通过人工智能 CT 图像识别和血清自身抗体联合提高术前恶性肺结节的识别效率。
Eur Radiol. 2023 May;33(5):3092-3102. doi: 10.1007/s00330-022-09317-x. Epub 2022 Dec 8.
5
Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant Diagnosis.使用12种微小RNA组合和列线图辅助诊断非小细胞肺癌的早期检测
Front Oncol. 2020 Jun 11;10:855. doi: 10.3389/fonc.2020.00855. eCollection 2020.
6
Case study of an autoantibody panel for early detection of lung cancer and ground-glass nodules.用于肺癌和磨玻璃结节早期检测的自身抗体检测组合的案例研究。
J Cancer Res Clin Oncol. 2020 Dec;146(12):3349-3357. doi: 10.1007/s00432-020-03309-4. Epub 2020 Jul 9.
7
Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer.基于 CT 影像学、临床和血液学特征的综合列线图预测局部晚期非小细胞肺癌患者的生存情况。
Eur Radiol. 2019 Jun;29(6):2958-2967. doi: 10.1007/s00330-018-5949-2. Epub 2019 Jan 14.
8
EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays.早期细胞角蛋白片段检测(EarlyCDT®-Lung):通过额外的自身抗体检测提高临床应用价值。
Tumour Biol. 2012 Oct;33(5):1319-26. doi: 10.1007/s13277-012-0379-2. Epub 2012 Apr 11.
9
A nomogram from the SEER database for predicting the prognosis of patients with non-small cell lung cancer.SEER 数据库中的列线图预测非小细胞肺癌患者的预后。
Int J Biochem Cell Biol. 2020 Oct;127:105825. doi: 10.1016/j.biocel.2020.105825. Epub 2020 Sep 6.
10
Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.肿瘤相关自身抗体在肺癌早期诊断中的意义
Clin Respir J. 2018 Jun;12(6):2020-2028. doi: 10.1111/crj.12769. Epub 2018 Feb 15.

引用本文的文献

1
Biomarkers for the diagnosis of indeterminate pulmonary nodules: are we there yet?用于诊断不明确肺结节的生物标志物:我们做到了吗?
J Thorac Dis. 2025 Aug 31;17(8):6265-6282. doi: 10.21037/jtd-2024-2010. Epub 2025 Jul 23.
2
Cost-effectiveness assessment of liquid biopsy for early detection of lung cancer in Brazil.巴西液体活检用于肺癌早期检测的成本效益评估。
PLoS One. 2025 Jul 29;20(7):e0328631. doi: 10.1371/journal.pone.0328631. eCollection 2025.
3
Precise diagnosis and prognosis assessment of malignant lung nodules: a narrative review.

本文引用的文献

1
Five tumor-associated autoantibodies expression levels in serum predict lung cancer and associate with poor outcome.血清中五种肿瘤相关自身抗体的表达水平可预测肺癌并与不良预后相关。
Transl Cancer Res. 2019 Aug;8(4):1364-1373. doi: 10.21037/tcr.2019.07.25.
2
Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer.先前抗生素治疗与癌症患者免疫检查点抑制剂治疗的生存和应答的相关性。
JAMA Oncol. 2019 Dec 1;5(12):1774-1778. doi: 10.1001/jamaoncol.2019.2785.
3
Diagnostic Value of Autoantibodies in Lung Cancer: a Systematic Review and Meta-Analysis.
恶性肺结节的精准诊断与预后评估:一项叙述性综述
J Thorac Dis. 2024 Nov 30;16(11):7999-8013. doi: 10.21037/jtd-24-1058. Epub 2024 Nov 29.
4
A Novel IgG-IgM Autoantibody Panel Enhances Detection of Early-stage Lung Adenocarcinoma from Benign Nodules.一种新型IgG-IgM自身抗体检测组合提高了从良性结节中检测早期肺腺癌的能力。
Genomics Proteomics Bioinformatics. 2025 Jan 15;22(6). doi: 10.1093/gpbjnl/qzae085.
5
The diagnostic efficacy of seven autoantibodies in early detection of ground-glass nodular lung adenocarcinoma.七种自身抗体在磨玻璃结节型肺腺癌早期检测中的诊断效能
Front Oncol. 2024 Nov 26;14:1499140. doi: 10.3389/fonc.2024.1499140. eCollection 2024.
6
Biomarkers Suitable for Early Detection of Intrathoracic Cancers in Primary Care: A Systematic Review.适用于基层医疗中胸内癌症早期检测的生物标志物:一项系统综述
Cancer Epidemiol Biomarkers Prev. 2025 Jan 9;34(1):19-34. doi: 10.1158/1055-9965.EPI-24-0713.
7
USP10 promotes cell proliferation, migration, and invasion in NSCLC through deubiquitination and stabilization of EIF4G1.USP10 通过去泛素化和稳定 EIF4G1 促进 NSCLC 中的细胞增殖、迁移和侵袭。
Sci Rep. 2024 Oct 10;14(1):23685. doi: 10.1038/s41598-024-74490-6.
8
An analysis of the influencing factors of false negative autoantibodies in patients with non-small cell lung cancer.非小细胞肺癌患者自身抗体假阴性的影响因素分析
Front Oncol. 2024 May 10;14:1358387. doi: 10.3389/fonc.2024.1358387. eCollection 2024.
9
Clinical application of serum seven tumour-associated autoantibodies in patients with pulmonary nodules.血清七种肿瘤相关自身抗体在肺结节患者中的临床应用
Heliyon. 2024 May 3;10(9):e30576. doi: 10.1016/j.heliyon.2024.e30576. eCollection 2024 May 15.
10
EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation.早期 CT 肺血检测在肺部实性结节危险度分级中的应用:系统评价和经济评估。
Health Technol Assess. 2022 Dec;26(49):1-184. doi: 10.3310/IJFM4802.
自身抗体在肺癌中的诊断价值:一项系统评价与Meta分析
Cell Physiol Biochem. 2018;51(6):2631-2646. doi: 10.1159/000495935. Epub 2018 Dec 11.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
Liquid biopsy for early stage lung cancer.早期肺癌的液体活检
J Thorac Dis. 2018 Apr;10(Suppl 7):S876-S881. doi: 10.21037/jtd.2018.04.26.
6
Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.肺癌筛查,版本 3.2018,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2018 Apr;16(4):412-441. doi: 10.6004/jnccn.2018.0020.
7
Early detection of lung cancer by using an autoantibody panel in Chinese population.在中国人群中使用自身抗体组合早期检测肺癌。
Oncoimmunology. 2017 Oct 16;7(2):e1384108. doi: 10.1080/2162402X.2017.1384108. eCollection 2018.
8
Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement.评估用于肺癌早期检测的分子生物标志物:生物标志物何时可用于临床?美国胸科学会官方政策声明。
Am J Respir Crit Care Med. 2017 Oct 1;196(7):e15-e29. doi: 10.1164/rccm.201708-1678ST.
9
The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer.IASLC 肺癌分期项目:第八版肺癌 TNM 分类中 TNM 分期分组修订的外部验证。
J Thorac Oncol. 2017 Jul;12(7):1109-1121. doi: 10.1016/j.jtho.2017.04.011. Epub 2017 Apr 28.
10
Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial.使用EarlyCDT®-Lung Test(ECLS)检测血液中肿瘤抗原自身抗体作为肺癌病例发现方法:一项随机对照试验的研究方案。
BMC Cancer. 2017 Mar 11;17(1):187. doi: 10.1186/s12885-017-3175-y.